78.69 M
About PSYBIO THERAPEUTICS CORP
Sector
Industry
CEO
Evan M. Levine
Headquarters
Vancouver
Founded
2009
FIGI
BBG0108BFCN7
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PSYBF is 0.000001 USD — it hasn't changed in the past 24 hours. Watch PsyBio Therapeutics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PsyBio Therapeutics Corp. stocks are traded under the ticker PSYBF.
PSYBF reached its all-time high on May 6, 2021 with the price of 0.790000 USD, and its all-time low was 0.000001 USD and was reached on Sep 18, 2024. View more price dynamics on PSYBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PSYBF stock is 0.00% volatile and has beta coefficient of 23.27. Track PsyBio Therapeutics Corp. stock price on the chart and check out the list of the most volatile stocks — is PsyBio Therapeutics Corp. there?
Yes, you can track PsyBio Therapeutics Corp. financials in yearly and quarterly reports right on TradingView.
No, PSYBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PSYBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PsyBio Therapeutics Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PsyBio Therapeutics Corp. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PsyBio Therapeutics Corp. stock shows the sell signal. See more of PsyBio Therapeutics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.